Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Eukaryotic translation initiation factor 3 subunit L pseudogene 1 (EIF3LP1) is a pseudogene related to the eukaryotic translation initiation factor 3 complex, particularly subunit L (EIF3L). While the protein-coding eIF3L is a component of the eIF3 multi-subunit complex—which plays a central role in the initiation of eukaryotic translation and is implicated in processes such as cancer, cell growth, and protein synthesis—EIF3LP1 itself does not encode a functional protein and is not a druggable target. There is no reported literature indicating a functional, regulatory, or disease-associated non-coding RNA role for this pseudogene. Thus, EIF3LP1 is not relevant as a therapeutic target, biomarker, or mechanism of drug action. If you intended to refer to the functional protein eIF3L (rather than the pseudogene EIF3LP1), information would differ significantly: it would then describe an active translation initiation factor involved in mRNA processing, ribosomal binding, and potentially implicated in disease processes including cancer. For EIF3LP1, however, all evidence supports classification solely as a non-target pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Eukaryotic translation initiation factor 3 subunit L pseudogene 1 (EIF3LP1).